Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Seal

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
Advances in Therapy|October 14, 2022
Real-World Analysis of Treatment Patterns, Healthcare Utilization, Costs, and Mortality Among People with Biliary Tract Cancers in the USAMarcus J Healey, Brian Seal, Nicole Princic, et al.
Journal of Hepatocellular Carcinoma|December 23, 2021
Clinical Characteristics, Treatment Patterns, and Healthcare Costs and Utilization for Hepatocellular Carcinoma (HCC) Patients Treated at a Large Referral Center in Washington State 2007-2018Veena Shankaran, Shasank Chennupati, Hayley Sanchez, et al.
Journal of the American Geriatrics Society|July 1, 2009
Effect of age on survival benefit of adjuvant chemotherapy in elderly patients with Stage III colon cancerIlene H Zuckerman, Thomas Rapp, Ebere Onukwugha, et al.
Current Medical Research and Opinion|March 10, 2017
Disease burden of systemic light-chain amyloidosis: a systematic literature reviewHuamao Mark Lin, Xin Gao, Catherine E Cooke, et al.
Journal of Occupational and Environmental Medicine|February 6, 2010
Assessing the relationship between compliance with antidepressant therapy and employer costs among employees in the United StatesHoward G Birnbaum, Rym Ben-Hamadi, David Kelley, et al.
Future Oncology (London, England)|December 6, 2019
Real-world incidence and cost of pneumonitis post-chemoradiotherapy for Stage III non-small-cell lung cancerKellie J Ryan, Damion Nero, Bruce A Feinberg, et al.
Patient Preference and Adherence|January 24, 2022
Patient and Caregiver Preferences for First-Line Treatments of Metastatic Non-Small Cell Lung Cancer: A Discrete Choice ExperimentCandice Yong, M Janelle Cambron-Mellott, Brian Seal, et al.
Future Oncology (London, England)|February 13, 2015
Evaluating treatments and corresponding costs of prostate cancer patients treated within an inpatient or hospital-based outpatient settingBrian Seal, Sean D Sullivan, Scott Ramsey, et al.
Leukemia & Lymphoma|October 19, 2017
Real-world effectiveness of brentuximab vedotin versus physicians' choice chemotherapy in patients with relapsed/refractory Hodgkin lymphoma following autologous stem cell transplantation in the United Kingdom and GermanyErin A Zagadailov, Shelby Corman, Viktor Chirikov, et al.
Applied Health Economics and Health Policy|July 10, 2014
Comparing hospital-based resource utilization and costs for prostate cancer patients with and without bone metastasesBrian Seal, Sean D Sullivan, Scott D Ramsey, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Advances in Therapy|October 14, 2022
Real-World Analysis of Treatment Patterns, Healthcare Utilization, Costs, and Mortality Among People with Biliary Tract Cancers in the USAMarcus J Healey, Brian Seal, Nicole Princic, et al.
Journal of Hepatocellular Carcinoma|December 23, 2021
Clinical Characteristics, Treatment Patterns, and Healthcare Costs and Utilization for Hepatocellular Carcinoma (HCC) Patients Treated at a Large Referral Center in Washington State 2007-2018Veena Shankaran, Shasank Chennupati, Hayley Sanchez, et al.
Journal of the American Geriatrics Society|July 1, 2009
Effect of age on survival benefit of adjuvant chemotherapy in elderly patients with Stage III colon cancerIlene H Zuckerman, Thomas Rapp, Ebere Onukwugha, et al.
Current Medical Research and Opinion|March 10, 2017
Disease burden of systemic light-chain amyloidosis: a systematic literature reviewHuamao Mark Lin, Xin Gao, Catherine E Cooke, et al.
Journal of Occupational and Environmental Medicine|February 6, 2010
Assessing the relationship between compliance with antidepressant therapy and employer costs among employees in the United StatesHoward G Birnbaum, Rym Ben-Hamadi, David Kelley, et al.
Future Oncology (London, England)|December 6, 2019
Real-world incidence and cost of pneumonitis post-chemoradiotherapy for Stage III non-small-cell lung cancerKellie J Ryan, Damion Nero, Bruce A Feinberg, et al.
Patient Preference and Adherence|January 24, 2022
Patient and Caregiver Preferences for First-Line Treatments of Metastatic Non-Small Cell Lung Cancer: A Discrete Choice ExperimentCandice Yong, M Janelle Cambron-Mellott, Brian Seal, et al.
Future Oncology (London, England)|February 13, 2015
Evaluating treatments and corresponding costs of prostate cancer patients treated within an inpatient or hospital-based outpatient settingBrian Seal, Sean D Sullivan, Scott Ramsey, et al.
Leukemia & Lymphoma|October 19, 2017
Real-world effectiveness of brentuximab vedotin versus physicians' choice chemotherapy in patients with relapsed/refractory Hodgkin lymphoma following autologous stem cell transplantation in the United Kingdom and GermanyErin A Zagadailov, Shelby Corman, Viktor Chirikov, et al.
Applied Health Economics and Health Policy|July 10, 2014
Comparing hospital-based resource utilization and costs for prostate cancer patients with and without bone metastasesBrian Seal, Sean D Sullivan, Scott D Ramsey, et al.
Pageof 6